Interferon as a Cell Product
Everyone is aware of the long lag period between the general notion of the clinical potential of interferon, developed some twenty years ago, and the actual application of interferon in clinical practice. Today we are at a stage when practical sources of human interferon for clinical trials are finally being developed and it is becoming possible to produce quantities of interferon that — though still relatively modest — will allow a thorough evaluation of interferon’s clinical potential.
KeywordsNewcastle Disease Virus Cell Substrate Human Interferon Antiviral State Interferon Activity
Unable to display preview. Download preview PDF.
- 3.Paucker, K., Cantell, K., Henle, W. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 17: 324–334, 1962.Google Scholar
- 12.Mogensen, K.E., Cantell, K. Stability of human leukocyte interferon towards heat. Acta Path. Microbiol. Scand. B. 81: 382–383. 1973.Google Scholar
- 14.Sonnenfeld, G., Mandel A.D., Merigan, T.C. Immunomodulating activitiy and characterization of type II interferon. Fed. Proc. 36: 1229. 1977.Google Scholar
- 15.Gardner, L.J., Vilcek, J. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts. J. Gen. Virol. (in press).Google Scholar
- 17.Kuwata, T., Fuse, A., Suzuki, et al. Comparison of suppression of cell and virus growth in human transformed cells by leukocyte and fibroblast interferon. J. Gen. Virol. (in press).Google Scholar
- 19.Jordan, G.W., Fried, R.P., Merigan, T.C. Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating antiviral activity and host responses to infection. J. Inf. Dis. 130: 56–62. 1974.Google Scholar
- 20.Weimar, W., Heitjink, R.A., Schalm, S.W. et al. Fibroblast interferon in HBsAg-positive chronic active hepatitis. Lancet ii: 1282. 1977.Google Scholar
- 24.Cantell, K., Hirvonen, S., Mogensen, K.E. et al. Human leukocyte interferon: Production, purification, stability, and animal experiments. The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections-In vitro. Edited by C. Waymouth. Monograph no. 3, pp/ 35–38. 1974.Google Scholar
- 31.Havell, E.A., Vilček, J. Production of high-titered interferon in cultured of human diploid cells. Antimicrob. Ag. Chemother. 2: 476–484. 1972.Google Scholar
- 32.Mozes, L.W., Havell, E.A., Gradoville, M.L. et al. increased interferon in human cells irradiated with ultraviolet light. Infec. Immun. 10: 1189–1191. 1974.Google Scholar
- 33.Vilček, J., Havell, E.A., Gradoville, M.L. et al. Selection of new human foreskin fibroblast cell strains for interferon production. Human Interferon, Production and Clinical Use. Edited by W. R. Stinebring, P. J. Chappie. New York, Plenum Press, pp. 101–118. 1978.Google Scholar
- 34.Billiau, A., Edy, V.G., Heremans, H. Human interferon: Mass production in a newly established cell line, MG-63. Antimicrob. Ag. Chemother. 12: 11–15. 1977.Google Scholar